Support for Stem cell research in cardiology

  • 113 views
Uploaded on

Market report on Stem Cell Research in Cardiology emphasizes on the market for stem cells in Cardiology. The study is segmented by Source (Allogenic and Autogenic) and by Type (Bone Marrow Stem Cells, …

Market report on Stem Cell Research in Cardiology emphasizes on the market for stem cells in Cardiology. The study is segmented by Source (Allogenic and Autogenic) and by Type (Bone Marrow Stem Cells, Embryonic Stem Cells, and Other). Estimations and Predictions for 2005-2020 are graphically illustrated by geographic regions encompassing North America, Europe, Asia-Pacific, and Rest of World. Business profiles of 25 major companies are discussed in the report. The text is complemented by 25 exhibits. The report serves as a guide to global market for Stem Cells in Cardiology covering more than 230 companies that are engaged in stem cell R&D, storage, banking, discovery, testing and supply of products and services. Major Contract Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Compilation of Worldwide Patents and Research related to Stem Cell Research in Cardiology is also provided. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
113
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. RITMIR024: Stem Cell Research in Cardiology – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 1 STEM CELL RESEARCH IN CARDIOLOGY- MARKET SIZE AND OPPORTUNITIES Scope of the Study Heart disease has assumed great magnitude as an endemic health problem. Cardiology field has seen significant efforts in clinical research in the past few years with the development of new drugs and surgical modalities of therapy as well. However, the mortality rates remain very high. In this context, stem cell applications in cardiology assume great significance since stem cells have been found to be successfully used in tissue regeneration. Heart disease, including myocardial infarction and ischemia, can be treated with the applications of stem cells. This report emphasizes on the market for stem cells in Cardiology. The study is segmented by Source (Allogenic and Autogenic) and by Type (Bone Marrow Stem Cells, Embryonic Stem Cells, and Other). Projections and estimates are graphically illustrated by geographic region encompassing North America, Europe, Asia-Pacific, and Rest of World. Business profiles of 23 major companies are discussed in the report. The report serves as a guide to global market for Stem Cell Research in Cardiology covering 229 companies that are engaged in stem cell R&D, storage, banking, discovery, testing and supply of products and services. Major Contract Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Stem Cell Research in Cardiology report is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in--  Gauging Competitive Intelligence  Identifying Key Growth Areas and Opportunities  Understanding Geographic Relevance to Product  Knowing Regional Market Sizes and Growth Opportunities and Restraints  Keeping Tab on Emerging Technologies  Equity Analysis  Tapping New Markets Analytics and data presented in this report pertain to several parameters such as -  Global And Regional Market Sizes, Market Shares, Market Trends  Product (Global And Regional) Market Sizes, Market Shares, Market Trends  Technology Trends  Corporate Intelligence  Key Companies By Sales, Brands, Products  Consumer Behavioral Patterns  Other Strategic Business Affecting Data
  • 2. RITMIR024: Stem Cell Research in Cardiology – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 2 Research Methodology RI Technologies publishes business intelligence reports by going through a cycle of diligent research and analysis activity. Research is done using both online and offline resources. The study outline of this report is sketched on the following lines - global market analysis, regional market analysis, product segmentation, global and regional market analysis by product segment, market trends, M&A, R&D, competitive landscape, technology trends, and other key drivers. Current data helps in analyzing the future of the industry and is also helpful for doing market evaluations, and estimating the market size for the future. This report is uniquely researched and the methodology includes:  Need and Scope of Study  Product Definitions  Segmental Analysis  Regional Analysis  Exclusive Data Analytics  Corporate Intelligence  Feedback Right from concept to final compilation of this report, both primary and secondary research methods are applied. We have provided exclusive feedback forms/pre-release questionnaires for this report to use the information for authentication of our own findings. Secondary research includes government publications, investment research reports, web based surveys, website information of both companies and markets, and other offline resources such as print publications and CDs. Our compilation of easy to navigate PDF reports are essential value addition resources for leading and growing companies.
  • 3. RITMIR024: Stem Cell Research in Cardiology – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 3 II. REPORT SYNOPSIS The Role of Stem Cells in Repairing the Heart A study was recently conducted wherein it was conclusively proved that stem cell therapies do have a future role to play in the repairing of the heart. Human adult stem cells extracted from the bone marrow can produce vascular endothelial cells after their transplantation is effected into rats. In one such study using the rat model, the left anterior descending coronary artery was manually constricted and thus a heart attack was induced. A population of human hematopoietic stem cells was diligently identified as they obviously cause the production of new blood vessels. This investigation was similar to the Jackson study. The stem cells were seen to exhibit the property of plasticity. Now, plasticity in stem cells signifies that the cells could develop into cell types that they would routinely not tend to become. These stem cells were then made use of in the formation of new blood vessels in the damaged portions of the heart. Thereby, proliferation of the preexisting vasculature was encouraged, following the induced heart attack. Thus, it is observed that human hematopoietic stem cells have the potential to develop into an array of tissue types including cardiac musculature given the suitable culture conditions. The human hematopoietic stem cells were first injected into the bloodstream that entered into the damaged heart of the rat model. It was noted that these cells could obviate the cessation of the thickened or hypertrophied myocardial cells. These myocardial cells though damaged were viable. The investigation also noted the reduction of the progressive development of collagen scars and fibers. The other groups of rats, which were surgically treated in a controlled condition, that had their left anterior descending coronary arteries intact, or those, that had their left anterior descending coronary arteries ligated, were observed. It was found that those control rats that were injected with control cells or saline did not exhibit any enhancement in their quantity of blood vessels. The identification of the hematopoietic cells could be performed on the basis of highly specific cell markers. Eventually, it is possible to differentiate them from cardiomyocyte precursor cells. Thus the cells can be utilized as they are, or in association with other pharmacological therapies, or myocyte-regeneration designs. Human embryonic stem cell research is a subject that is attracting immeasurable attention. So much so, that new findings in the area of cardiomyocyte regeneration are regularly taking place. Human embryonic stem cells have shown their capability to differentiate into any cell type in the adult human body and have therefore become a new source population presenting the potential to change into cardiac-repair cells. This was pioneered by Itskovitz-Eldor and associates who showed the world that the human embryonic stem cells can reproducibly differentiate, given appropriate culture, into embryoid bodies comprising of cell types, which exist in the human body’s three embryonic germ layers.
  • 4. RITMIR024: Stem Cell Research in Cardiology – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 4 Among the different cell types, can be found cells that exhibited the physical appearance of cardiomyocytes. These cells showed cellular markers that had the properties of heart cells. When they were carefully studied under a microscope, they were found to demonstrate contractile activity akin to cardiomyocytes. At the early part of research activity in this field, the functional and structural attributes of the initial stage of cardiomyocytes in the cells that develop from the embryoid bodies, were displayed. Those cells that exhibit contracting activity readily were identified with the use of markers. The markers were used with antibodies to proteins that exist in the heart tissue. The proteins in the heart tissue are cardiac troponin, antinaturietic protein, desmin, myosin heavy chain and alpha-actinin. Upon conducting a genetic analysis of these cells it was noticed that the transcription-factor genes that were expressed were in conformity with early stage cardiomyocytes. The electrical recordings from these cells were then carefully observed. In this study, it was seen that changes did take place in the calcium-ion movement inside the cells. Another factor namely, the contractile responsiveness to catecholamine hormone stimulation by the cells was studied. It was found that these observations were akin to responsiveness, changes and recordings that were made in early cardiomyocytes, when mammalian development was being investigated into. Segmentation of Stem Cells in Cardiology Exhibit 1. Segmentation of Global Stem Cells Market in Cardiology by Source and by Type Source Stem Cell Type Allogenic Bone Marrow Stem Cells Autogenic Embryonic Stem Cells - *Other *Cord Blood Cells etc. © RIT, 2013
  • 5. RITMIR024: Stem Cell Research in Cardiology – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 5 Global Market Analysis Global Stem Cells in Cardiology market is projected to reach about US$XX.XX billion by 2020 from an estimated US$XX.XX billion in 2012, growing at a robust compounded annual growth rate (CAGR) of XX.XX% during the analysis period 2005-2020. Exhibit 2. Stem Cells in Cardiology - Global Value Market Estimations & Predictions (2005-2020) in US$ Million Year Value 2005 XX.XX 2006 XX.XX 2007 XX.XX 2008 XX.XX 2009 XX.XX 2010 XX.XX 2011 XX.XX 2012 XX.XX 2013 XX.XX 2014 XX.XX 2015 XX.XX 2016 XX.XX 2017 XX.XX 2018 XX.XX 2019 XX.XX 2020 XX.XX CAGR% XX.XX © RIT Figures, 2013 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 US$ Million
  • 6. RITMIR024: Stem Cell Research in Cardiology – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 6 Exhibit 3. List of Major Global Companies Company Region Website Aastrom Biosciences, Inc. USA www.aastrom.com Advanced Cell Technology, Inc. USA www.advancedcell.com Axordia Limited UK www.axordia.com Cellartis AB Sweden www.cellartis.com CellSeed, Inc. Japan www.cellseed.com CordLife Ltd Australia www.cygenics.com Gamida Cell Ltd. Israel www.gamida-cell.com More… © RIT, 2013
  • 7. RITMIR024: Stem Cell Research in Cardiology – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 7 III. MARKET DYNAMICS Market Overview Stem cells give advanced information about how an organism develops from a single cell and how healthy cells replace damaged cells in adult organisms. This is a very promising area of science and has huge disease-curing applications. Stem cells are as much part of controversy as they are exciting. They possess the potential for curing diseases including Alzheimer’s, Diabetes, Huntington’s and Parkinson’s. Stem cell research itself is controversial as the stem cells are derived from embryos. Growth of stem cells market worldwide is basically driven by the potential of stem cells for the various diseases. For example, embryonic stem cells are capable of generating new tissues and organs to replace the damaged tissues and organs. Exhibit 4. Stem Cells in Cardiology by Source - Global Value Market Estimations & Predictions (2005 – 2020) for Allogenic and Autogenic Stem Cell Transplantation in US$ Million Year/Region Allogenic Autogenic Total 2005 XX.XX XX.XX XX.XX 2006 XX.XX XX.XX XX.XX 2007 XX.XX XX.XX XX.XX 2008 XX.XX XX.XX XX.XX 2009 XX.XX XX.XX XX.XX 2010 XX.XX XX.XX XX.XX 2011 XX.XX XX.XX XX.XX 2012 XX.XX XX.XX XX.XX 2013 XX.XX XX.XX XX.XX 2014 XX.XX XX.XX XX.XX 2015 XX.XX XX.XX XX.XX 2016 XX.XX XX.XX XX.XX 2017 XX.XX XX.XX XX.XX 2018 XX.XX XX.XX XX.XX 2019 XX.XX XX.XX XX.XX 2020 XX.XX XX.XX XX.XX CAGR% XX.XX XX.XX XX.XX © RIT, 2013 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 US$ Million Allogenic Autogenic
  • 8. RITMIR024: Stem Cell Research in Cardiology – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 8 IV. PRODUCT/TECHNOLOGY RESEARCH Ever since scientists discovered the great potential that stem cells have in the repair and regeneration of the body, they have wondered whether stem cells in the heart can generate new tissue to repair damages such as those caused by a heart attack. Now investigations have revealed a reservoir of stem cells that could indeed help generate new cells in case of damage to the heart. Experiments with cardiac stem cells isolated in rats show that they have the ability to repair injured tissue when injected into the heart. Stem cell therapy is seen as an ideal method for treating cardiac disorders associated with heart muscle injury. Pre-clinical studies in animal models of acute myocardial infarction appear to be promising for repairing damaged cardiac muscle and generating new blood vessel formation in the infarcted area. Stem cell research offers great therapeutic potential and is relevant to basic science researchers, clinicians and patients. Exhibit 5. Global Estimates of Number of Deaths Caused by Cardiovascular Diseases (2010) Disease Number of Deaths Ischaemic heart disease XX.XX Cerebrovascular disease XX.XX Hypertensive heart disease XX.XX Other Cardiovascular Diseases XX.XX © RIT Figures, 2013
  • 9. RITMIR024: Stem Cell Research in Cardiology – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 9 STEM CELLS IN CARDIOLOGY - OUTLOOK The concept of stem cell transplantation to regenerate the myocardium and better the working of the heart has received a great deal of attention in recent times. Small-scale studies in the pre-clinical and clinical stages support the use of stem cells in treating heart disease. However similar such studies must be carried out on a larger-scale to corroborate the findings and prove stem cell therapy as a viable alternative method of treating patients with heart disease. Cells in heart’s muscle are not capable of replacing themselves, and therefore the heart does not return to normal functioning levels once some of these cells are damaged. Other than stem cells therapy and surgery, there are hardly any effective methods available for treating cardiovascular ailments. This leaves people with congestive heart failure, heart attack, and congenital heart diseases with little hope to improve their quality of life. Though transplanting of heart is an effective technique, donors of heart are few in number. This is where adult stem cell therapy comes in. Adult stem cells are able to coax the existing cells in the heart’s muscles to produce new heart-muscle cells. Adult stem cell therapy for treating heart diseases has been examined in medical tests for efficacy as well as adverse effects. These tests have proved that such stem cell therapy is much better and safer than many existing procedures for treating cardiovascular diseases. This is the reason adult stem cell therapy is gaining importance in cardiac stem cell research. The global market for Stem Cells in Cardiology is projected to reach about US$ XX.XX billion by 2020 at a CAGR of about XX.XX % from a market of about US$ XX.XX billion in 2012. Adult stem cells market is the largest tapped market while cord blood and embryonic stem cell markets, though with huge market potential, are still in infancy stages. Embryonic stem cells to treat cardiac disorders is the topic of Interest. But, due to its various ethical issues, is mired in debates all over the world…………………………….. About RI Technologies RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector. We emphasize on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology & Healthcare industry, tracking market trends, and forecasting industry based on specialized analysis. The life sciences sector is an ever growing marketplace with emerging technologies in areas of discovery, design and development. Research – As Good as the Methodology is!  Gauging Competitive Intelligence  Identifying Key Growth Areas and Opportunities  Understanding Geographic Relevance to Product
  • 10. RITMIR024: Stem Cell Research in Cardiology – A Market Insight Report, July 2013 © RI Technologies - www.researchimpact.com Sample Page - 10  Knowing Regional Market Sizes and Growth Opportunities and Restraints  Keeping Tab on Emerging Technologies  Equity Analysis  Tapping New Markets © COPYRIGHT The copyright and publication rights to all RI Technologies' reports and other products are the property of the company. Plagiarism of any kind accounts to violation of copyright laws. Any type of reproduction of the material without express permission is not allowed. The buyer, under no circumstances, shall license, resell or repackage, or sell data without prior permission of the company. DISCLAIMER RI Technologies sells content in good faith. The company is not liable to the buyer for any implications arising out of the usage of data for any particular purpose. The company makes no representations or warranties for the accuracy or completeness of the data. While extreme caution and effort is practiced for data compilation and presentation, the company does not accept any responsibility for findings in the study which are a cumulative effort of primary and secondary research resources. The studies do not endorse or promote any product or company. RI Technologies, its affiliates, partners, distributors, and contractors are not liable for inaccuracies or incompleteness of the reports. User discretion is recommended for the usage of the data.